Helen O. McCarthy

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

Jan A. Burger, Alessandra Tedeschi, Paul M. Barr et al. · New England Journal of Medicine · 2015 · 1.6K citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Hydrogel‐Forming Microneedle Arrays for Enhanced Transdermal Drug Delivery

Ryan F. Donnelly, Thakur Raghu Raj Singh, Martin J. Garland et al. · Advanced Functional Materials · 2012 · 693 citations · Full text

Pharmacy, Bioengineering, Biomedical Engineering +17

Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study

Jan A. Burger, Paul M. Barr, Tadeusz Robak et al. · Leukemia · 2019 · 463 citations · Full text

Medicine, Oncology, Pharmacology +16

A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study

Constantine S. Tam, Stephen Opat, Shirley D’Sa et al. · Blood · 2020 · 448 citations · Full text

Medicine, Hematology, Pharmacology +4

Hydrogel-Forming Microneedles Prepared from “Super Swelling” Polymers Combined with Lyophilised Wafers for Transdermal Drug Delivery

Ryan F. Donnelly, Maelíosa McCrudden, Ahlam Zaid Alkilani et al. · PLoS ONE · 2014 · 325 citations · Full text

Pharmacy, Bioengineering, Pharmaceutics +15